NCT06735209
- Conditions
- Infections, Malaria, Malaria, Falciparum, +4 more
- Locations
-
- The University of Washington - Virology Research Clinic Seattle, Washington, United States
Clinical trial condition
Malaria, Falciparum
Explore clinical trials studying Malaria, Falciparum. Study availability and eligibility vary by location and protocol.
379 public trials
18 recruiting studies
Malaria, Falciparum trial results
NCT06083688
- Conditions
- Anemia in Children, Infections, Malaria, +6 more
- Locations
-
- Malaria Alert Centre Blantyre, Malawi
NCT05978037
- Conditions
- Infections, Malaria, Malaria, Falciparum, +6 more
- Locations
-
- Centre for Clinical Vaccinology & Tropical Medicine (CCVTM) Oxford, Oxfordshire, United Kingdom
NCT06171113
- Conditions
- Infections, Malaria, Malaria, Falciparum, +4 more
- Locations
-
- GSK Investigational Site Cambridge, United Kingdom
NCT06347471
- Conditions
- Falciparum; Malaria, Infections, Malaria, +5 more
- Locations
-
- Dr. Ambrosoli Memorial Hospital Kalongo, Agago District, Uganda
- Patongo Health Facility IV Patongo, Agago District, Uganda
Completed
Study To Evaluate Safety, Tolerability, and Pharmacokinetics of MAM01 in African Population
NCT06408857
- Conditions
- Healthy Volunteers, Infections, Malaria, +5 more
- Locations
-
- JCRC-Joint Clinical Research Centre Kampala, Uganda
- IDRC-Infectious Disease Research Collaboration, IDRC Tororo Hospital Station Road Tororo, Uganda
NCT05357560
- Conditions
- Infections, Malaria, Malaria, Falciparum, +5 more
- Locations
-
- Medical Research Council Unit, Fajara Banjul, The Gambia
NCT07235033
- Conditions
- Infections, Malaria, Malaria, Falciparum, +5 more
- Locations
-
- Novartis Investigative Site Abidjan, Côte d’Ivoire
- Novartis Investigative Site Libreville, Gabon
- Novartis Investigative Site Ahero, Kenya
NCT04546633
- Conditions
- Infections, Malaria, Malaria, Falciparum, +5 more
- Locations
-
- Novartis Investigative Site Banfora, Burkina Faso
- Novartis Investigative Site Bobo-Dioulasso, Burkina Faso
- Novartis Investigative Site Ouagadougou, Burkina Faso
- Novartis Investigative Site Sabou, Burkina Faso
NCT06558643
- Conditions
- Infections, Malaria, Malaria, Falciparum, +5 more
- Locations
-
- Quotient Sciences Ruddington, Nottingham, United Kingdom